Comments
IOL Chemicals and Pharmaceuticals has informed the exchanges that it has completed the de-bottlenecking and re-engineering of its ibuprofen manufacturing facilities at Bamala at a cost of ₹24 crore. Post-completion, capacity of the ibuprofen units have increased to 6,200 tonnes per annum (TPA), the company said in the release, adding that these units are approved by the USFDA, ANVISA, EDQM, WHO and MOH Japan. Shares of IOL Chemicals surged 16.6 per cent at ₹98.85 on the NSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.